Alcresta Therapeutics
Alcresta Therapeutics is the developer of enzyme-based products designed to combat gastrointestinal disorders. Alcresta Therapeutics was acquired by Linden Capital Partners in March 2024.
Alcresta Therapeutics is active in the biotech space based in United States, founded in 2011.
Alcresta Therapeutics is positioned in biotech, a segment that rewards a clear, focused offering.
Its base of operations is United States.
The company is listed at the ACQUIRED BY: LINDEN CAPITAL PARTNERS | Bessemer portfolio company stage of development.
| Sector | Biotech |
|---|---|
| Country | United States |
| Founded | 2011 |
| Stage | ACQUIRED BY: LINDEN CAPITAL PARTNERS | Bessemer portfolio company |
Website: www.alcresta.com
Sign in to view the contact information we hold for Alcresta Therapeutics.
Create a free account
Create a free account